Article
Therapeutic Applications of Engineered Chimeric Antigen Receptors-T cell for Cancer Therapy
2021-10-25
Abstract excerpt
<h4>Findings: </h4> of new targeted treatments with adequate safety evaluations is essential for better cancer cures and mortality rates. Immunotherapy holds promise for patients with relapsed disease, with the ability to elicit long-term remissions. Emerging promising clinical results in B-cell malignancy using gene-altered T-lymphocytes uttering chimeric antigen receptors have sparked a lot of interest. This tre...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cc6acb01-d1fd-56b3-83ad-7cd895b35ac6
- DOI
- 10.20944/preprints202110.0368.v1
